Pamrevlumab Terminated Phase 2 Trials for Liver Fibrosis Due to Chronic Hepatitis B Infection Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01217632A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection